Bionime Corp. | Mutual Funds
Mutual Funds that own Bionime Corp.
DFA Emerging Markets Small Cap Series
202,000
0.34%
16,000
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
172,000
0.28%
0
0%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
13,000
0.02%
0
0%
04/30/2018
TIFF Multi Asset Fund
7,389
0.01%
0
0%
06/30/2018
DFA TA World (ex-US) Core Equity Portfolio
7,000
0.01%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
6,000
0.01%
6,000
0%
12/31/2017
| Address |
No. 100 Daqing Street Section 2
Taichung TX 40242
Taiwan
|
|
Employees
|
- |
| Website |
http://www.bionime.com |
| Updated |
07/08/2019 |
| Bionime Corp. engages in the provision of biotechnology and medical testing. It specializes in self monitoring blood glucose system covers self-monitor, hospital and clinic use, and accessories such as test strips and lancing device. The company was founded on April 14, 2003 and is headquartered in Taichung, Taiwan. |
